Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

PYXSPYXS
Showing 8 of 18 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in PYXIS ONCOLOGY INC

GEODE CAPITAL MANAGEMENT, LLC holds 598,121 shares of PYXS (PYXIS ONCOLOGY INC), worth $873,815 as of 2026-Q1. The position was increased (+3.6% shares). PYXS represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$873,815

Current Shares

598,121

Total Value Change

-$2.5M

Total Shares Change

-429,590

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
598,121
+3.6%
$873,8150.0%$1.43
26
2025-Q4
Increased
577,211
+6.0%
$664,2110.0%$1.09
18
2025-Q3
Increased
544,508
+6.6%
$1.2M0.0%$2.20
27
2025-Q2
Decreased
510,963
-53.9%
$562,2500.0%$1.10
0
2025-Q1
Increased
1.1M
+2.5%
$1.1M0.0%$1.06
26
2024-Q4
Decreased
1.1M
-0.2%
$1.7M0.0%$1.56
0
2024-Q3
Increased
1.1M
+5.5%
$4M0.0%$3.62
28
2024-Q2
Increased
1M
+202.2%
$3.4M0.0%$3.31
43

Other major holders of PYXS: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, Janus Henderson Group Ltd., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used